(Q43509438)

24 November 2017

title

Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis (English)

1 reference

24 November 2017

main subject

visceral leishmaniasis

1 reference

Alexander J

1 reference

24 November 2017

Carter KC

1 reference

24 November 2017

Al-Fasi N

1 reference

24 November 2017

Satoskar A

1 reference

24 November 2017

Brombacher F

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

European Journal of Immunology

24 November 2017

published in

1 reference

24 November 2017

1 reference

24 November 2017

1 reference

24 November 2017

page(s)

2935-2943

1 reference

Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

IL-4-deficient Balb/c mice resist infection with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

IL-13 is a susceptibility factor for Leishmania major infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

Interleukin-4 receptor alpha-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200010%2930%3A10%3C2935%3A%3AAID-IMMU2935%3E3.0.CO%3B2-Q

10.1002/1521-4141(200010)30:10<2935::AID-IMMU2935>3.0.CO;2-Q

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference